LeserbriefKommentar
Perioperative Apalutamide in High-Risk Localized Prostate Cancer
New England Journal of Medicine · 12.11.2026 · 395 (19) · 1965-1968
DOI: 10.1056/nejmc2611613 ↗Kurz gefasst
Leserbrief in der Zeitschrift New England Journal of Medicine, erschienen am 12.11.2026. Verfasst von Mary-Ellen Taplin. Beteiligte Einrichtung: Dana-Farber Cancer Institute, Boston. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Dana-Farber Cancer Institute, Boston.
Zitieren
APA
Taplin, M. E. (2026). Perioperative Apalutamide in High-Risk Localized Prostate Cancer. New England Journal of Medicine, 395(19), 1965-1968. https://doi.org/10.1056/nejmc2611613
Vancouver
Taplin ME. Perioperative Apalutamide in High-Risk Localized Prostate Cancer. New England Journal of Medicine. 2026;395(19):1965-1968. doi:10.1056/nejmc2611613
BibTeX
@article{Taplin2026,
author = {Taplin, Mary-Ellen},
title = {Perioperative Apalutamide in High-Risk Localized Prostate Cancer},
journal = {New England Journal of Medicine},
year = {2026},
volume = {395},
number = {19},
pages = {1965--1968},
doi = {10.1056/nejmc2611613}
}
EUVIMED